208 related articles for article (PubMed ID: 29876827)
1. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
Yashiro M; Matsuoka T; Ohira M
Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14.
Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M
Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
[TBL] [Abstract][Full Text] [Related]
5. Preclinical study of a "tailor-made" combination of NK4-expressing gene therapy and gefitinib (ZD1839, Iressa) for disseminated peritoneal scirrhous gastric cancer.
Namiki Y; Namiki T; Yoshida H; Date M; Yashiro M; Matsumoto K; Nakamura T; Yanagihara K; Tada N; Satoi J; Fujise K
Int J Cancer; 2006 Mar; 118(6):1545-55. PubMed ID: 16206271
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells.
Kushiyama S; Yashiro M; Yamamoto Y; Sera T; Sugimoto A; Nishimura S; Togano S; Kuroda K; Okuno T; Miki Y; Ohira M
Anticancer Res; 2022 Jan; 42(1):501-509. PubMed ID: 34969760
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.
Sai E; Miwa Y; Takeyama R; Kojima S; Ueno T; Yashiro M; Seto Y; Mano H
Cancer Sci; 2019 Aug; 110(8):2643-2651. PubMed ID: 31222839
[TBL] [Abstract][Full Text] [Related]
8. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice.
Fujita T; Yanagihara K; Takeshita F; Aoyagi K; Nishimura T; Takigahira M; Chiwaki F; Fukagawa T; Katai H; Ochiya T; Sakamoto H; Konno H; Yoshida T; Sasaki H
Cancer Sci; 2013 Feb; 104(2):214-22. PubMed ID: 23106787
[TBL] [Abstract][Full Text] [Related]
10. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract][Full Text] [Related]
11. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
[TBL] [Abstract][Full Text] [Related]
12. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts.
Yashiro M; Chung YS; Kubo T; Hato F; Sowa M
Br J Cancer; 1996 Oct; 74(7):1096-103. PubMed ID: 8855981
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms responsible for the progression of scirrhous gastric cancer].
Yashiro M; Ohira M; Muguruma K; Shinto O; Hirakawa K
Nihon Rinsho; 2012 Oct; 70(10):1812-6. PubMed ID: 23198567
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
[TBL] [Abstract][Full Text] [Related]
16. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus.
Murahashi K; Yashiro M; Takenaka C; Matsuoka T; Ohira M; Chung KH
Int J Oncol; 2001 Nov; 19(5):1029-33. PubMed ID: 11605005
[TBL] [Abstract][Full Text] [Related]
19. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
